Dalton Transactions
Paper
1
2/3
NMR (75.5 MHz, CDCl3): δ = 8.5 (d, JCP = 58.2 Hz, C-1a), 13.2 1JCP = 93.2 Hz, CCp,ipso), 70.4 (s, CCp′), 71.3 (d,
J
= 11.5 Hz,
CP
2
3
2/3
1
(s, C-1b), 23.4 (d, JCP = 16.2 Hz, C-2b), 23.7 (d, JCP = 4.5 Hz,
CCp), 73.8 (d,
J
CP
= 9.8 Hz, CCp), 120.0 (q, JCF = 321.5 Hz,
C-3b), 25.4 (d, JCP = 53.0 Hz, C-4b), 60.3 (d, JCP = 98.5 Hz, CF3) ppm; 19F NMR (282.4 MHz, CDCl3): δ = −78.8 ppm. MS
1
1
2/3
CCp,ipso), 70.3 (s, CCp′), 71.1 (d,
J
= 13.1 Hz, CCp), 74.0 (d, (ESI+, MeOH) m/z (%) = 373.1737 (100, [M − NTf2]+ requires
CP
2/3
1
J
= 10.5 Hz, CCp), 120.0 (q, JCF = 321.4 Hz, CF3) ppm; 19F 373.1743); MS (ESI−, MeOH) m/z (%) = 279.9177 (100, [NTf2]−
CP
NMR (282.4 MHz, CDCl3): δ = −78.8 ppm. MS (ESI+, MeOH) requires 279.9178). IR (neat): ν = 3110 (w), 2965 (m), 2937 (m),
m/z (%) = 303.0956 (100, [M − NTf2]+ requires 303.0960); MS 2877 (m), 1465 (w), 1414 (w), 1383 (w), 1346 (s), 1330 (s),
(ESI−, MeOH) m/z (%) = 279.9176 (100, [NTf2]− requires 1225 (m), 1176 (vs), 1134 (s), 1108 (m), 1098 (m), 1051 (s),
279.9178). IR (neat): ν = 3109 (w), 2964 (w), 2932 (m), 2877 (w), 1004 (m), 911 (w), 830 (m), 787 (m), 761 (m), 738 (m), 652 (m),
1467 (w), 1416 (w), 1346 (s), 1330 (s), 1225 (m), 1176 (vs), 613 (s), 599 (s), 568 (s), 509 (s), 486 (s), 465 (s) cm−1. E1/2
1133 (vs), 1108 (m), 1051 (vs), 1004 (m), 944 (s), 886 (m), ([EMIM]NTf2) = 453 mV vs. Fc/Fc+.
869 (m), 830 (s), 787 (s), 761 (m), 739 (m), 653 (m), 612 (s),
599 (s), 569 (s), 508 (s), 485 (s), 459 (m), 444 (m) cm−1. E1/2 nyl)imide (5f) [FcPBu3]NTf2. 5f was prepared according to
([EMIM]NTf2) = 463 mV vs. Fc/Fc+.
method A and C. Method A: 4f (193 mg, 0.41 mmol, 1.0 eq.)
Tributylferrocenylphosphonium bis(trifluoromethanesulfo-
Dibutylmethylferrocenylphosphonium bis(trifluoromethane- and lithium bis(trifluoromethanesulfonyl)imide (119 mg,
sulfonyl)imide (5d) [FcPBu2Me]NTf2. 5d was prepared accord- 0.41 mmol, 1.0 eq.); 244 mg (0.37 mmol, 89%) orange solid.
ing to method A. 4d (199 mg, 0.58 mmol, 1.0 eq.) and lithium Method C: 8b (222 mg, 0.83 mmol, 1.2 eq.) and [(C5H5)Fe(η6-
bis(trifluoromethanesulfonyl)imide (167 mg, 0.58 mmol, toluene)]NTf2 (343 mg, 0.70 mmol, 1.0 eq.); 444 mg
1.0 eq.); 264 mg (0.42 mmol, 72%) orange oil. Anal. calc. for (0.67 mmol, 95%) orange solid. Anal. calc. for C24H36F6Fe-
C21H30F6FeNO4PS2 (625.42 g mol−1) C 40.33, H 4.83, N 2.24%; NO4PS2 (667.50 g mol−1) C 43.19, H 5.44, N 2.10%; found C
found C 40.68, H 5.01, N 2.55%. 31P{1H} NMR (121.5 MHz, 43.47, H 5.55, N 2.45%. 31P{1H} NMR (121.5 MHz, CDCl3): δ =
3
CDCl3): δ = 30.0 ppm; 1H NMR (300.1 MHz, CDCl3): δ = 0.95 (t, 32.1 ppm; 1H NMR (300.1 MHz, CDCl3): δ = 0.97 (t, JHH
=
3JHH = 6.8 Hz, 6H, H-1a), 1.43–1.55 (m, 8H, H-2a, H-3a), 2.07 6.8 Hz, 9H, H-1a), 1.47–1.62 (m, 12H, H-2a, H-3a), 2.24–2.33
2
3
(d, JHP = 13.2 Hz, 3H, H-1b), 2.20–2.32 (m, 4H, H-4a), 4.37 (s, (m, 6H, H-4a), 4.36 (s, 5H, HCp′), 4.54 (d, JHH = 1.6 Hz, 2H,
3/4
3/4
3
5H, HCp′), 4.56 (q,
J
HH
= 1.8 Hz, 2H, HCp), 4.74 (q,
J
=
HH
H
Cp), 4.76 (d, JHH = 1.6 Hz, 2H, HCp) ppm; 13C{1H} NMR
1.8 Hz, 2H, HCp) ppm; 13C{1H} NMR (75.5 MHz, CDCl3): δ = (75.5 MHz, CDCl3): δ = 13.3 (s, C-1a), 21.3 (d, JCP = 51.0 Hz,
1
1
1
2
3
6.6 (d, JCP = 57.3 Hz, C-1b), 13.3 (s, C-1a), 22.9 (d, JCP
52.2 Hz, C-4a), 23.6 (d, JCP = 15.9 Hz, C-2a), 23.8 (d, JCP
4.5 Hz, C-3a), 59.8 (d, JCP = 96.1 Hz, CCp,ipso), 70.3 (s, CCp′),
71.2 (d,
=
=
C-4a), 23.7 (d, JCP = 15.7 Hz, C-3a), 24.0 (d, JCP = 4.6 Hz,
C-2a), 59.3 (d, JCP = 93.3 Hz, CCp,ipso), 70.4 (s, CCp′), 71.3 (d,
3
2
1
1
2/3
2/3
J
= 11.5 Hz, CCp), 73.8 (d,
J
CP
= 9.8 Hz, CCp), 120.0 (q,
CP
2/3
2/3
J
= 12.3 Hz, CCp), 73.9 (d,
J
= 10.2 Hz, CCp), 1JCF = 321.9 Hz, CF3) ppm; 19F NMR (282.4 MHz, CDCl3): δ =
CP
CP
120.0 (q, JCF = 321.5 Hz, CF3) ppm; 19F NMR (282.4 MHz, −78.8 ppm. MS (ESI+, MeOH) m/z (%) = 387.1894 (100, [M −
CDCl3): δ = −78.8 ppm. MS (ESI+, MeOH) m/z (%) = 345.1425 NTf2]+ requires 387.1899); MS (ESI−, MeOH) m/z (%) =
(100, [M − NTf2]+ requires 345.1429); MS (ESI−, MeOH) m/z 279.9177 (100, [NTf2]− requires 279.9178). IR (neat): ν =
(%) = 279.9177 (100, [NTf2]− requires 279.9178). IR (neat): ν = 3114 (w), 2966 (m), 2937 (m), 2877 (w), 1466 (w), 1409 (w),
3109 (w), 2964 (m), 2936 (m), 2876 (m), 1720 (vw), 1466 (w), 1383 (w), 1348 (s), 1336 (s), 1222 (m), 1180 (vs), 1138 (s),
1415 (w), 1347 (s), 1330 (s), 1225 (s), 1176 (vs), 1134 (vs), 1107 (m), 1099 (m), 1051 (s), 1036 (s), 1003 (m), 968 (w),
1108 (m), 1051 (vs), 1004 (m), 969 (w), 928 (m), 882 (m), 907 (m), 894 (w), 850 (m), 824 (s), 789 (m), 761 (w), 738 (m),
1
830 (m), 787 (m), 761 (m), 739 (m), 652 (m), 613 (s), 599 (s), 724 (m), 613 (s), 568 (s), 512 (s), 486 (s), 467 (s), 407 (m) cm−1
569 (s), 509 (s), 486 (s), 463 (s) cm−1. E1/2 ([EMIM]NTf2) = Tm: 72.4 °C (Td: 327.4 °C). Single crystals suitable for
454 mV vs. Fc/Fc+.
XRD obtained by slow diffusion of Et2O into an acetonitrile
Dibutylpropylferrocenylphosphonium bis(trifluoromethane- solution. E1/2 ([EMIM]NTf2) = 454 mV vs. Fc/Fc+.
.
sulfonyl)imide (5e) [FcPBu2Pr]NTf2. 5e was prepared accord-
Dihexylmethylferrocenylphosphonium bis(trifluoromethane-
ing to method A. 4f (203 mg, 0.45 mmol, 1.0 eq.) and lithium sulfonyl)imide (5g) [FcPHex2Me]NTf2. 5g was prepared accord-
bis(trifluoromethanesulfonyl)imide (129 mg, 0.45 mmol, ing to method B. 2c (570 mg, 1.48 mmol, 1.0 eq.) and MeNTf2
1.0 eq.); 240 mg (0.37 mmol, 82%) orange oil. Anal. calc. for (479 mg, 1.62 mmol, 1.1 eq.); 860 mg (1.26 mmol, 85%) red
C23H34F6FeNO4PS2 (653.47 g mol−1) C 42.27, H 5.24, N 2.14%; oil. Anal. calc. for C25H38F6FeNO4PS2 (681.51 g mol−1) C 44.06,
found C 42.48, H 5.35, N 2.35%. 31P{1H} NMR (121.5 MHz, H 5.62, N 2.06%; found C 44.39, H 5.69, N 2.30%. 31P{1H}
1
CDCl3): δ = 31.8 ppm; 1H NMR (300.1 MHz, CDCl3): δ = 0.97 (t, NMR (121.5 MHz, CDCl3): δ = 29.9 ppm; H NMR (300.1 MHz,
3
4
3
3JHH = 6.9 Hz, 6H, H-1a), 1.15 (dt, JHH = 7.2 Hz, JHP = 1.5 Hz, CDCl3): δ = 0.88 (t, JHH = 6.9 Hz, 9H, H-1a), 1.23–1.35 (m, 8H,
2
3H, H-1b), 1.46–1.57 (m, 8H, H-2a, H-3a), 1.60–1.72 (m, 2H, H-2a, H-3a), 1.40–1.60 (m, 8H, H-4a, H-5a), 2.07 (d, JPH
=
H-2b), 2.22–2.32 (m, 6H, H-4a, H-3b), 4.36 (s, 5H, HCp′), 4.53 13.2 Hz, 3H, H-1b), 2.16–2.34 (m, 4H, H-6a), 4.37 (s, 5H, HCp′),
3
3
3
3
(q, JHH = 1.89 Hz, 2H, HCp), 4.75 (q, JHH = 1.9 Hz, 2H, HCp
)
4.55 (q, JHH = 1.8 Hz, 2H, HCp), 4.74 (q, JHH = 1.8 Hz, 2H,
ppm; 13C{1H} NMR (75.5 MHz, CDCl3): δ = 13.3 (s, C-1a), 15.3
H
Cp) ppm; 13C{1H} NMR (75.5 MHz, CDCl3): δ = 6.6 (d, JCP
=
1
3
2
2
(d, JCP = 16.7 Hz, C-1b), 15.9 (d, JCP = 4.4 Hz, C-2b), 21.3 (d, 57.3 Hz, C-1b), 13.8 (s, C-1a), 21.8 (d, JCP = 4.3 Hz, C-5a),
1JCP = 51.0 Hz, C-4a), 23.5 (d, JCP = 50.7 Hz, C-3b), 23.7 (d, 22.3 (s, C-2a), 23.1 (d, JCP = 51.9 Hz, C-6a), 30.1 (d, JCP
=
1
1
3
2JCP = 15.7 Hz, C-3a), 24.0 (d, JCP = 4.5 Hz, C-2a), 59.2 (d, 15.4 Hz, C-4a), 30.9 (s, C-3a), 59.8 (d, JCP = 95.9 Hz, CCp,ipso),
3
1
This journal is © The Royal Society of Chemistry 2014
Dalton Trans., 2014, 43, 3750–3766 | 3761